Synapse - American Society of Clinical Oncology

American Society of Clinical Oncology

SHERPA: White

People

Motzer
Scher
O'Reilly
Saltz
Bajorin
Kris
Hudis
Morris
Rosenberg
Robson

Groups

Department of Medicine (6402)
Solid Tumor Oncology Division (5540)
Survivorship Research (1997)
Genitourinary Oncology Service (1768)
Surgery (1638)
Epidemiology and Biostatistics (1495)
GSK Faculty (1389)
Population Sciences Research Program (1379)
Gastrointestinal Oncology Service (1354)
Hematologic Malignancies, Division of (1282)

Search Within

Results (9183)

Export to EndNote / Excel

Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma

Meeting Abstract

Westin, J.; Oluwole, O. O.; Kersten, M. J.; Miklos, D. B.; Perales, M. A.; Ghobadi, A.; Rapoport, A.; Sureda, A.; Jacobson, C. A.; Farooq, U.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results

Meeting Abstract

Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Oh, D. Y.; Banerjee, S. N.; Martin, A. G.; Jung, K. H.; Lugowska, I. A.; Manso, L.; Manzano, A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of atezolizumab plus cabozantinib vs cabozantinib alone after progression with prior immune checkpoint inhibitor (ICI) treatment in metastatic renal cell carcinoma (RCC): Primary PFS analysis from the phase 3, randomized, open-label CONTACT-03 study

Meeting Abstract

Choueiri, T. K.; Albiges, L.; Tomczak, P.; Suáez, C.; Voss, M. H.; de Velasco, G.; Chahoud, J.; Procopio, G.; Mahammedi, H.; Zengerling, F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR-mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study

Meeting Abstract

Yang, J. C. H.; Lee, D. H.; Lee, J. S.; Fan, Y.; de Marinis, F.; Okamoto, I.; Inoue, T.; Cid, J. R. R.; Zhang, L.; Yang, C. T.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048)

Meeting Abstract

Schrag, D.; Shi, Q.; Weiser, M. R.; Gollub, M. J.; Saltz, L. B.; Musher, B. L.; Goldberg, J.; Al Baghdadi, T.; Goodman, K. A.; McWilliams, R. R.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

INDIGO: A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation

Meeting Abstract

Mellinghoff, I. K.; Van Den Bent, M. J.; Blumenthal, D. T.; Touat, M.; Peters, K. B.; Clarke, J. L.; Mendez, J. S.; Welsh, L.; Mason, W. P.; Hottinger, A. F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)

Journal Article

Basch, E.; Dueck, A. C.; Mitchell, S. A.; Mamon, H.; Weiser, M.; Saltz, L.; Gollub, M.; Rogak, L.; Ginos, B.; Mazza, G. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer

Journal Article

Chi, K. N.; Rathkopf, D.; Smith, M. R.; Efstathiou, E.; Attard, G.; Olmos, D.; Lee, J. Y.; Small, E. J.; Gomes, Ajpds; Roubaud, G.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)